Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1544)

« Back to Publications

The economic burden of COVID-19 undervaccination: costs of hospitalisation, ICU admission, and death in Scotland

Kerr S. et al, (2026), Health Economics Review, 16

Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

Zheng B. et al, (2026), Nature Communications, 17

Asthma exacerbation risk after short-term air pollution exposure varies by age, sex, severity, and eosinophil count: East London cohort study

Hajmohammadi H. et al, (2026), Respiratory Research, 27

Mitigating algorithmic unfairness arising from forgetfulness of medical records in clinical artificial intelligence

Chen Y. et al, (2026), Nature Communications, 17

Ensuring participant safety in research studies evaluating digital mental health interventions delivered remotely - insights from the PIPA trial of an online parenting intervention to prevent affective disorders in high-risk adolescents

Madan J. et al, (2026), BMC Medical Research Methodology, 26

Viral cultures for assessing airborne infectiousness of SARS-CoV-2: a systematic review and meta-analysis

Onakpoya IJ. et al, (2026), BMC Infectious Diseases, 26

Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients. Reply.

Butler CC. et al, (2026), N Engl J Med, 395

Burden and economic impact of RSV hospitalisations among English adults, 2023/24

Truong T. et al, (2026), Journal of Infection, 93

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic

Stokes L. et al, (2026), Transfusion

Cost-Effectiveness of Community-Based Repurposed Therapies for COVID-19 in the PRINCIPLE Trial

PNG ME. et al, (2026), Cost Effectiveness and Resource Allocation

Compliance with existing standards: overview comparing Cochrane with non-Cochrane living systematic reviews.

Golob MM. et al, (2026), Syst Rev

Recording of Pharmacy First consultations in general practice records in England: an observational study of the service's first year using OpenSAFELY.

Kingsley VJ. et al, (2026), Br J Gen Pract

Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study

Parker EPK. et al, (2026), Ebiomedicine, 129

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study

Gardiner LE. et al, (2026), International Journal of Infectious Diseases, 168

Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY.

Russell MD. et al, (2026), Lancet Rheumatol

Load More

1
2
3
4
5
6
7
...
»